Annual Retained Earnings
-$635.57 M
-$11.39 M-1.82%
December 31, 2023
Summary
- As of February 7, 2025, RSLS annual retained earnings is -$635.57 million, with the most recent change of -$11.39 million (-1.82%) on December 31, 2023.
- During the last 3 years, RSLS annual retained earnings has fallen by -$120.75 million (-23.45%).
- RSLS annual retained earnings is now -25282.35% below its all-time high of -$2.50 million, reached on December 31, 2003.
Performance
RSLS Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Retained Earnings
-$640.94 M
-$1.58 M-0.25%
September 30, 2024
Summary
- As of February 7, 2025, RSLS quarterly retained earnings is -$640.94 million, with the most recent change of -$1.58 million (-0.25%) on September 30, 2024.
- Over the past year, RSLS quarterly retained earnings has dropped by -$7.07 million (-1.11%).
- RSLS quarterly retained earnings is now -3633.45% below its all-time high of -$17.17 million, reached on December 31, 2005.
Performance
RSLS Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Retained Earnings Formula
Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid
RSLS Retained Earnings Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -1.8% | -1.1% |
| 3 y3 years | -23.4% | -18.4% |
| 5 y5 years | -51.7% | -26.6% |
RSLS Retained Earnings Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -10.0% | at low | -10.9% | at low |
| 5 y | 5-year | -28.9% | at low | -30.0% | at low |
| alltime | all time | <-9999.0% | at low | -3633.4% | at low |
ReShape Lifesciences Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -$640.94 M(+0.2%) |
| Jun 2024 | - | -$639.36 M(+0.3%) |
| Mar 2024 | - | -$637.77 M(+0.3%) |
| Dec 2023 | -$635.57 M(+1.8%) | -$635.57 M(+0.3%) |
| Sep 2023 | - | -$633.88 M(+0.6%) |
| Jun 2023 | - | -$630.34 M(+0.6%) |
| Mar 2023 | - | -$626.85 M(+0.4%) |
| Dec 2022 | -$624.19 M(+8.0%) | -$624.19 M(+2.9%) |
| Sep 2022 | - | -$606.36 M(+2.0%) |
| Jun 2022 | - | -$594.55 M(+1.6%) |
| Mar 2022 | - | -$584.98 M(+1.2%) |
| Dec 2021 | -$577.97 M(+12.3%) | -$577.97 M(+6.8%) |
| Sep 2021 | - | -$541.30 M(+3.4%) |
| Jun 2021 | - | -$523.60 M(+0.8%) |
| Mar 2021 | - | -$519.70 M(+0.9%) |
| Dec 2020 | -$514.83 M(+4.4%) | -$514.83 M(+1.7%) |
| Sep 2020 | - | -$506.29 M(+1.0%) |
| Jun 2020 | - | -$501.11 M(+0.7%) |
| Mar 2020 | - | -$497.51 M(+0.9%) |
| Dec 2019 | -$493.20 M(+17.7%) | -$493.20 M(+5.4%) |
| Sep 2019 | - | -$468.14 M(+6.5%) |
| Jun 2019 | - | -$439.39 M(+3.8%) |
| Mar 2019 | - | -$423.47 M(+1.1%) |
| Dec 2018 | -$418.99 M(+25.2%) | -$418.99 M(+6.8%) |
| Sep 2018 | - | -$392.22 M(+1.9%) |
| Jun 2018 | - | -$385.09 M(+11.3%) |
| Mar 2018 | - | -$345.99 M(+3.4%) |
| Dec 2017 | -$334.76 M(+11.2%) | -$334.76 M(+3.0%) |
| Sep 2017 | - | -$325.14 M(+3.2%) |
| Jun 2017 | - | -$315.15 M(+2.2%) |
| Mar 2017 | - | -$308.31 M(+2.4%) |
| Dec 2016 | -$300.94 M(+8.4%) | -$300.94 M(+1.5%) |
| Sep 2016 | - | -$296.51 M(+2.2%) |
| Jun 2016 | - | -$289.98 M(+1.8%) |
| Mar 2016 | - | -$284.99 M(+2.7%) |
| Dec 2015 | -$277.58 M | -$277.58 M(+2.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2015 | - | -$270.81 M(+1.6%) |
| Jun 2015 | - | -$266.66 M(+2.9%) |
| Mar 2015 | - | -$259.26 M(+2.8%) |
| Dec 2014 | -$252.08 M(+11.6%) | -$252.08 M(+2.5%) |
| Sep 2014 | - | -$245.90 M(+2.4%) |
| Jun 2014 | - | -$240.19 M(+3.2%) |
| Mar 2014 | - | -$232.69 M(+3.0%) |
| Dec 2013 | -$225.95 M(+12.9%) | -$225.95 M(+3.0%) |
| Sep 2013 | - | -$219.38 M(+3.0%) |
| Jun 2013 | - | -$213.08 M(+3.1%) |
| Mar 2013 | - | -$206.75 M(+3.3%) |
| Dec 2012 | -$200.17 M(+13.3%) | -$200.17 M(+3.6%) |
| Sep 2012 | - | -$193.15 M(+3.1%) |
| Jun 2012 | - | -$187.30 M(+2.7%) |
| Mar 2012 | - | -$182.35 M(+3.2%) |
| Dec 2011 | -$176.71 M(+17.2%) | -$176.71 M(+4.8%) |
| Sep 2011 | - | -$168.66 M(+4.5%) |
| Jun 2011 | - | -$161.36 M(+3.6%) |
| Mar 2011 | - | -$155.80 M(+3.4%) |
| Dec 2010 | -$150.72 M(+13.0%) | -$150.72 M(+2.7%) |
| Sep 2010 | - | -$146.76 M(+3.1%) |
| Jun 2010 | - | -$142.37 M(+3.1%) |
| Mar 2010 | - | -$138.12 M(+3.6%) |
| Dec 2009 | -$133.37 M(+31.6%) | -$133.37 M(+2.2%) |
| Sep 2009 | - | -$130.48 M(+10.1%) |
| Jun 2009 | - | -$118.47 M(+9.6%) |
| Mar 2009 | - | -$108.11 M(+6.7%) |
| Dec 2008 | -$101.31 M(+59.7%) | -$101.31 M(+8.4%) |
| Sep 2008 | - | -$93.49 M(+12.2%) |
| Jun 2008 | - | -$83.29 M(+15.8%) |
| Mar 2008 | - | -$71.93 M(+13.4%) |
| Dec 2007 | -$63.43 M(+82.0%) | -$63.43 M(+16.0%) |
| Sep 2007 | - | -$54.69 M(+56.9%) |
| Dec 2006 | -$34.86 M(+103.0%) | -$34.86 M(+103.0%) |
| Dec 2005 | -$17.17 M(+585.6%) | -$17.17 M |
| Dec 2003 | -$2.50 M | - |
FAQ
- What is ReShape Lifesciences annual retained earnings?
- What is the all time high annual retained earnings for ReShape Lifesciences?
- What is ReShape Lifesciences annual retained earnings year-on-year change?
- What is ReShape Lifesciences quarterly retained earnings?
- What is the all time high quarterly retained earnings for ReShape Lifesciences?
- What is ReShape Lifesciences quarterly retained earnings year-on-year change?
What is ReShape Lifesciences annual retained earnings?
The current annual retained earnings of RSLS is -$635.57 M
What is the all time high annual retained earnings for ReShape Lifesciences?
ReShape Lifesciences all-time high annual retained earnings is -$2.50 M
What is ReShape Lifesciences annual retained earnings year-on-year change?
Over the past year, RSLS annual retained earnings has changed by -$11.39 M (-1.82%)
What is ReShape Lifesciences quarterly retained earnings?
The current quarterly retained earnings of RSLS is -$640.94 M
What is the all time high quarterly retained earnings for ReShape Lifesciences?
ReShape Lifesciences all-time high quarterly retained earnings is -$17.17 M
What is ReShape Lifesciences quarterly retained earnings year-on-year change?
Over the past year, RSLS quarterly retained earnings has changed by -$7.07 M (-1.11%)